v3.25.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2025
Dec. 31, 2024
Current Assets    
Cash and cash equivalents $ 10,014,000 $ 11,609,000
Tax credit receivable 1,587,000 3,228,000
Prepaid expenses and other current assets 875,000 1,444,000
Total Current Assets 12,476,000 16,281,000
Non-Current Assets    
Property and equipment, net 253,000 270,000
Restricted cash 100,000 96,000
Right of use asset 1,171,000 1,272,000
In-process research and development 18,084,000 17,358,000
Deposits and other assets 77,000 75,000
Total Assets 32,161,000 35,352,000
Current Liabilities:    
Accounts payable 437,000 859,000
Accrued expenses 3,769,000 3,368,000
Contingent consideration, current portion 1,309,000  
Accrued employee benefits 554,000 1,144,000
Deferred research and development tax credit-current portion 1,460,000 1,614,000
Loans payable-current 51,000 61,000
Operating lease liability-current portion 568,000 539,000
Total Current Liabilities 8,148,000 7,585,000
Non-current Liabilities    
Non-current contingent consideration 5,685,000 6,973,000
Loan Payable - non-current 1,504,000 92,000
Non-current deferred research and development tax credit 595,000 762,000
Non-current operating lease liability 732,000 873,000
Total Liabilities 16,664,000 16,285,000
Commitments and Contingencies (Note 13)
Stockholders' Equity:    
Common stock, $0.001 par value; 350,000,000 shares authorized, 2,811,258 issued and 2,782,449 outstanding at March 31, 2025 and 2,811,258 issued and 2,782,449 outstanding at December 31, 2024 3,000 3,000
Additional paid-in capital 355,601,000 355,501,000
Treasury stock at cost, 28,809 shares at March 31, 2025 and at December 31, 2024 (288,000) (288,000)
Accumulated other comprehensive loss (524,000) (1,178,000)
Accumulated deficit (339,295,000) (334,971,000)
Total Stockholders' Equity 15,497,000 19,067,000
Total Liabilities and Stockholders' Equity $ 32,161,000 $ 35,352,000